RACHEL SCHIFF to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications RACHEL SCHIFF has written about Antineoplastic Agents, Immunological.
Connection Strength
0.841
-
HER2-Positive Breast Cancer Treatment and Resistance. Adv Exp Med Biol. 2025; 1464:495-525.
Score: 0.810
-
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition. Mol Cancer Ther. 2018 05; 17(5):921-930.
Score: 0.032